MBX Biosciences, Inc. MBX Income Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $79.16M+37.9% | $57.42M— | ||
| $18.9M+75.3% | $10.78M— | ||
| $98.06M+43.8% | $68.19M— | ||
| -$98.06M-43.8% | -$68.19M— | ||
| -$87M-40.5% | -$61.92M-90.2% | ||
| -$2.37— | —— | ||
| -$97.72M-43.9% | -$67.89M— | ||
| -$98.06M-43.8% | -$68.19M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is MBX Biosciences, Inc. profitable?
- MBX Biosciences, Inc. is not currently profitable: it reported a net loss of $86.6M over the trailing twelve months.
- What is MBX Biosciences, Inc.'s earnings per share?
- MBX Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.16.
- Where does MBX Biosciences, Inc.'s income statement data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.